ID
37145
Descripción
Study ID: 104864/502 Clinical Study ID: 104864/502 Study Title: An Open-Label, Multicenter, Randomized, Phase II Study of Oral Topotecan Daily x 5 Days vs. Oral Topotecan 5 Days On, 2 Days Off for 3 Weeks for Second-Line Treatment in Patients with Recurrent, Locally Advanced or Metastatic Cervical Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: N/A Study Indication: Cancer, Locally Advanced or Metastatic Cervical Cancer
Palabras clave
Versiones (1)
- 4/7/19 4/7/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
4 de julio de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Oral Topotecan Daily x 5 Days vs. Oral Topotacan 5 Days On, 2 Days Off; 104864/502
Adverse Experiences (Non-serious)
- StudyEvent: ODM
Descripción
Adverse Experiences (Non-serious)
Alias
- UMLS CUI-1
- C1518404
Descripción
Non-serious Adverse Event
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1518404
Descripción
Non-serious Adverse Event, Start Date, Start Time
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0808070
- UMLS CUI [1,3]
- C1301880
Descripción
Non-serious Adverse Event, End Date, End Time
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [1,3]
- C1522314
Descripción
Non-serious Adverse Event, Adverse Event Outcome
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C1705586
Descripción
Non-serious Adverse Event, Course
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0750729
Descripción
Non-serious Adverse Event. Course, Number of episodes
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0750729
- UMLS CUI [1,3]
- C4086638
Descripción
Non-serious Adverse Event, Toxicity Grade
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2826262
Descripción
Non-serious Adverse Event, Action Taken with Study Treatment
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C1704758
Descripción
Non-serious Adverse Event, Relationships, Experiment drug
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0304229
Descripción
Non-serious Adverse Event, Therapeutic Procedure
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0087111
Descripción
Non-serious Adverse Event, Withdraw
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2349954
Similar models
Adverse Experiences (Non-serious)
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])
C1705586 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C4086638 (UMLS CUI [1,3])
C2826262 (UMLS CUI [1,2])
C1704758 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])